Thromb Haemost 2004; 91(02): 388-393
DOI: 10.1160/TH03-07-0442
Cell Signalling and Vessel Remodelling
Schattauer GmbH

Long term prognosis of patients with myocardial infarction and normal coronary angiography: impact of inherited coagulation disorders

Antoine Da Costa
1   Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France
,
Brigitte Tardy
2   Division of Hematology, Saint-Etienne, France
,
Kamel Haouchette
1   Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France
,
Patrick Mismetti
3   Division of Clinical Pharmacology, Saint-Etienne, France
,
Alexis Cerisier
1   Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France
,
Michel Lamaud
1   Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France
,
Denis Guyotat
2   Division of Hematology, Saint-Etienne, France
,
Karl Isaaz
1   Division of Cardiology, University Jean Monnet of Saint-Etienne, Saint-Etienne, France
› Author Affiliations
Further Information

Publication History

Received 05 July 2003

Accepted after revision 24 October 2003

Publication Date:
01 December 2017 (online)

Summary

The prognosis of patients with myocardial infarction (MI) and normal coronary arteries (NCA) in the presence of an inherited coagulation disorder is unknown. The purpose of this study was to compare the clinical thrombosis outcome of patients with (GpI) or without (GpII), inherited coagulation disorders, who suffered from an acute MI with NCA. Eighty two consecutive patients (mean age 49 ± 15 years; 29 females) with MI, but NCA, were recruited. Twelve patients (15%) had an inherited coagulation disorder. GpI and GpII were statistically similar regarding age (45 ± 11 vs 50 ± 16 years-old), gender (33 vs. 36% female), tobacco consumption (50 vs. 53%), diabetes mellitus (8 vs. 10%), hypertension (25 vs. 17%), obesity (8.3 vs. 14%), family history of coronary heart disease (33 vs. 19%), hypercholesterolemia (50 vs. 21%; p = . 08), left ventricular ejection fraction (58 ± 13 vs. 61 ± 13%) and spasm (8.3% vs. 17%). All patients were initially treated with antiplatelet agents with the exception of one (8%) in GpI, and 6 (9%) in GpII who were taking oral anticoagulant therapy (ns). The mean follow-up was 57 ± 26 (range from 2-91 months). During the outcome, 12/78 (15.4%) thrombosis events occurred, including venous thrombosis or pulmonary embolism (1/12 vs. 1/66), reinfarction (2/12 vs. 4/66), and stroke (2/12 vs. 2/66), with two events in one patient (GpI). Kaplan-Meier event-free survival, with combined end-point, defined as venous thrombo-embolic event, reinfarction, or stroke differed between the two groups: 4/12 (33.3%) in GpI and 7/66 (10.6%) in Gp II (p <. 02). Patients with MI, NCA and congenital coagulation disorder present a high risk of thrombosis recurrence under antiplatelet agent.

Presented in part at the 52nd Annual Scientific Session of the American College of Cardiology; March 30-April 2, Chicago USA 2003, Abstract.

 
  • References

  • 1 Bruschke AVG, Bryneel KKJ, Bloch A. et al. Acute myocardial infarction without obstructive coronary artery disease demonstrated by selective cine arteriography. Br Heart J 1971; 33: 585-94.
  • 2 Arnett EN, Roberts WC. Acute myocardial infarction and angiographically normal coronary arteries. Circulation 1976; 53: 395-400.
  • 3 Rosenblatt A, Selzer A. The nature and clinical features of myocardial infarction with normal coronary artriogram. Circulation 1977; 55: 578-80.
  • 4 Erlebacher JA. Transmural myocardial infarction with “normal“ coronary arteries. Am Heart J 1979; 98: 421-30.
  • 5 Betriu A, Pare JC, Sanz GI. et al. Myocardial infarction with normal coronary arteries: a prospective clinical-angiographic study. Am J Cardiol 1981; 48: 28-32.
  • 6 Proudfit WL, Welch C, Siqueira C. et al. Prognosis of 1000 young women studied by coronary angiography. Circulation 1981; 64: 1185-90.
  • 7 Legrand V, Deliege M, Henrard L. et al. Patients with myocardial infarction and normal coronary arteriogram. Chest 1982; 06: 678-85.
  • 8 Ciraulo DA, Bresnahan GF, Frankel PS. et al. Transmural myocardial infarction with normal coronary angiograms and with single vessel coronary obstruction. Chest 1983; 02: 196-202.
  • 9 Lindsay J, Pichard AD. Acute mycocardial infarction with normal coronary arteries. Am J Cardiol 1984; 54: 902-4.
  • 10 Morris DC, Hurst JW, Logue RB. Myocardial infarction in young women. Am J Cardiol 1976; 38: 299-304.
  • 11 Khan AH, Haywood LJ. Myocardial infarction in nine patients with radiologically patent coronary arteries. N Engl J Med 1974; 291: 427-31.
  • 12 Proudfit WL, Bruschke AVG, Sones FM. Clinical course of patients with normal and slightly or moderatly abnormal coronary arteriograms: 10-years follow-up of 521 patients. Circulation 1980; 62: 712-7.
  • 13 McKenna WJ, Schew CYC, Oakley CM. Myocardial infarction with normal coronary angiogram: possible mechanisms of smoking risk in coronary artery disease. Br Heart J 1980; 43: 493-8.
  • 14 Thompson SI, Vieweg WVR, Alpert JS. et al. Incidence and age distribution of patients with myocardial infarction and normal coronary arteriograms. Cathet Cardiovasc Diagn 1977; 03 (03) 1-9.
  • 15 Raymond R, Lynch J, Underwood D. et al. Myocardial infarction and normal coronary arteriography : ten year clinical and risk analysis of 74 patients. J Am Coll Cardiol 1988; 11: 471-7.
  • 16 Alpert JS. Myocardial infarction with angiographically normal coronary arteries. Arch Intern Med 1994; 154: 265-9.
  • 17 Alpert JS. Myocardial infarction with angiographically normal coronary arteries. Arch Intern Med 1994; 154: 245.
  • 18 Sharifi M, Frohlich TG, Silverman IM. Myocardial infarction with angiographically normal coronary arteries. Chest 1995; 107: 36-40.
  • 19 Fournier JA, Sanchez-Gonzales A, Quero J. et al. Normal angiogram after myocardial infarction in young patients: a prospective clinical angiographic and long term follow-up study. Int J Cardiol 1997; 60: 281-7.
  • 20 Maggi A, Metra M, Niccoli L. et al. Prognosis in patients with myocardial infarction and angiographically normal coronary arteries. Cardiologia 1994; 39: 235-41.
  • 21 Zimmerman FH, Cameron A, Fisher LD. et al. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (coronary artery surgery registry). J Am Coll Cardiol 1995; 26: 654-61.
  • 22 Fournier JA, Sanchez A, Quero J. et al. Myocardial infarction in men aged 40 years or less: a prospective clinical angiographic study. Clin Cardiol 1996; 19: 631-6.
  • 23 Cheitlin MD, Mc Allister HA, De Castro CM. Myocardial infarction without atherosclerosis. JAMA 1975; 231: 951-8.
  • 24 Heupler FA. Syndrome of symptomatic coronary arterial spasm with nearly normal coronary angiograms. Am J Cardiol 1979; 45: 873-81.
  • 25 Gersh BJ, Bassendine MF, Forman R. et al. Coronary artery spasm and myocardial infarction in the absence of angiographically demonstrable obstructive coronary disease. Mayo CLin Pro 1981; 56: 700-8.
  • 26 Bott-Silverman C, Heupler FA. Natural history of pure coronary artery spasm in patients treated medically. J Am Coll Cardiol 1983; 02: 200-5.
  • 27 Vincent GM, Anderson JL, Marshall HW. Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med 1983; 309: 220-3.
  • 28 Conti CR. Myocardial infarction: thoughts about pathogenesis and the role of coronary spasm. Am Heart J 1985; 110: 187-93.
  • 29 Madias JE. The long term outcome of patients who suffered an acute myocardial infarction in the midst of recurrent attacks of variant angina. Clin Cardiol 1986; 09: 227-84.
  • 30 Di Clemente D, Borghi A, Morgagni CL, Costa GM. et al. Acute myocardial infarction with normal coronary arteries: role of microvascular dysfunction. Cardiologia 1994; 39: 827-34.
  • 31 Brecker SJD, Stevenson RN, Roberts R. et al. Acute myocardial infarction in patients with normal coronary arteries. BMJ 1993; 307: 1255-6.
  • 32 Da Costa A, Guy JM, Rousset H. et al. Antiphospholipids and the heart. Arch Mal Coeur 1993; 307: 1256-7.
  • 33 Holm J, Zöller B, Svensson PJ. et al. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994; 344: 952-3.
  • 34 Kyriakidis M, Androulakis A, Triposkiadis F. et al. Lack of a thrombotic tendency in patients with acute myocardial infarction and angiographically normal coronary arteries. Circulation 1995; 86: 22-4.
  • 35 Ardissino D, Peyvandi F, Merlini PA. et al. Factor V (Arg 506-Gln) mutation in young survivors of myocardial infarction. Thromb Haemost 1996; 75: 701-2.
  • 36 Da Costa A, Tardy Br, Isaaz K. et al. Prevalence of factor V Leiden and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart 1998; 80: 338-40.
  • 37 Mansourati J, Da Costa A, Munier S. et al. Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thromb Haemost 2000; 83: 822-5.
  • 38 Isner JM, Estes NAM, Thompson PD. et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 1438-43.
  • 39 Minor RL, Scott BD, Brown DD. et al. Cocaine induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991; 115: 797-806.
  • 40 Regan TJ, Wu CF, Weisse AB. et al. Acute myocardial infarction in toxic cardiomyopathy without coronary obstruction. Circulation 1975; 51: 453-61.
  • 41 Zainea M, Duvernoy WFC, Chauhan A, David S, Soto E, Small D. Acute myocardial infarction in angiographically normal coronary arteries following induction of general anesthesia. Arch Intern Med 1994; 154: 2495-8.
  • 42 Gonzales M, Herandez E, Aranda JM. et al. Acute myocardial infarction due to intracoronary occlusion after elective cardioversion for atrial fibrillation in a patient with angiographically nearly normal coronary arteries. Am Heart J 1981; 102: 932-4.
  • 43 Da Costa A, Isaaz K, Faure E. et al. Clinical Characteristics, Etiologic Factors and Long-Term Prognosis of Myocardial Infarction With Absolutely Normal Coronary Angiogram: A 3 Years Follow-up Study of 91 patients. Eur Heart J 2001; 22: 1459-65.
  • 44 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci 1994; 91: 1396-400.
  • 45 Van de Water NS, French JK, Lund M. et al. Prevalence of factor V Leiden and prothrombin variant G2021A in patients age<50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol 2000; 36: 717-22.
  • 46 Ridker PM, Miletich JP, Stampfer MJ. et al. Factor V Leiden and risk of recurrent idiopathic venous thromboembolism. Circulation 1995; 92: 2800-02.